• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Alphyn Begins CLEAR-AD1 Phase 2b Trial for Atopic Dermatitis

    PR NEWSWIRE

    Alphyn starts CLEAR-AD1 Phase 2b trial of Zabalafin Hydrogel

    PR NEWSWIRE

    Zabalafin Hydrogel for Atopic Dermatitis Presented at AAD Meeting

    PR NEWSWIRE

    Alphyn Gets FDA Clearance for Atopic Dermatitis Drug Study

    PR NEWSWIRE

    Alphyn Granted Patent for 1st-in-Class Atopic Dermatitis Treatment

    PR NEWSWIRE

    Alphyn Biologics Publishes Paper in Journal of Drugs in Dermatology

    PR NEWSWIRE

    Alphyn To Present Zabalafin Hydrogel Results At EADV Congress 2024

    PR NEWSWIRE

    Alphyn Receives Patent Allowance For Zabalafin Hydrogel

    PR NEWSWIRE

    Alphyn Announces Positive Results from Phase 2a Trial in Atopic Dermatitis

    PR NEWSWIRE

    Alphyn Reports Interim Results of Phase 2a Trial for Atopic Dermatitis

    PR NEWSWIRE

    Alphyn Biologics Presents New Data from Phase 2a Trial Showing Significant Improvement of Mild-to-Moderate Atopic Dermatitis

    PR NEWSWIRE

    Alphyn Biologics Reports +VE Pediatric Results pH 2a Atopic Dermatitis Trial

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.